Contact
Please use this form to send email to PR contact of this press release:
Share Dividend Announcement to Counter Short Selling at Upcoming Conference: NRx Pharmaceuticals (Nasdaq: NRXP)
TO:
Matthew Duffy, Chief Business Officer
NRx Pharmaceuticals, Inc.
484-254-6134